30Apr 2025
Remimazolam-Ketamine DAS Outperforms Propofol in AF Ablation Sedation

Remimazolam-Ketamine DAS Outperforms Propofol in AF Ablation Sedation

Remimazolam-ketamine deep analgosedation (DAS) for atrial fibrillation (AF) ablation was superior to propofol-opioid regimens in reducing sedation-related adverse events, particularly hypoxemia and hypotension. In a randomized trial involving 127 patients, 85.7% of propofol-opioid DAS patients experienced the primary endpoint (hypoxemia, hypotension, or intervention), compared to 27.9% in the remimazolam-ketamine DAS group.

  • #cardiology

Like

Save

Share